Épidémiologie, prise en chorge et coût du diobète de type 2 en France en 1998
Detournay B, Vauzelle-Kervroedan F, Charles MA et al. Épidémiologie, prise en chorge et coût du diobète de type 2 en France en 1998. Diabetes Metab 1999; 25: 356-65.
Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics
Wan Nazaimoon WM, Letchuman R, Noraini N et al. Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics. Diabetes Res Clin Pract 1999; 46: 213-21.
Stratégie de la prise en charge du patient diabétique de type II à l'exclusion de la prise en charge des complications
ANAES. Stratégie de la prise en charge du patient diabétique de type II à l'exclusion de la prise en charge des complications. Diabetes Metab 2000; 26: 232-43.
First International Study of Infarct Survival Collaborative Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1 Group
First International Study of Infarct Survival Collaborative Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1 Group. Lancet 1986; 2: 57-66.
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998; 317: 720-6.
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62.